To open this layer, scan the QR code below using any AR-link compatible browser, such as Layar, Wikitude or Junaio.
Or manually open this link: ar://cdp.interop.layar.com/bufotoadhoppala
Virta-Flaneurazine a potent programmable mood-changing drug.
Virta-Flaneurazine is an artists collective and pharmaceutical start-up, working on the development of a potent programmable mood-changing drug for online virtual and augmented worlds and other social networks.
Identified as part of the Wanderment family of psychotropic drugs, it causes the user to aimlessly roam the distant lands the Internet and mobile networks. Virta-Flaneurazine was developed to treat Wanderlust Deficit Disorder (WDD), or Internet Addiction, an increasingly common disorder characterized by rote repetitive Internet use and the inability of individuals to depart from their daily routines in their physical and virtual lives. As the prograchemistry takes effect, users find themselves erratically navigating to random Internet locations, behaving strangely, seeing digephemera and walking or flying in circuitous paths.
The *doctors/artists JC Freeman and WD Pappenheimer have developed a clinical trial program in order to test if Virta-Flaneurazine is effective in treating WDD and to determine if it is safe for human consumption. The clinical trials include an installation and participatory performance in a clinic setting that dispensed and evaluated the drug’s effects on volunteer subjects.